People | April 20, 2026
Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO
Move to accelerate cancer care expansion across India
Move to accelerate cancer care expansion across India
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
The FDA approval makes PD-L1 IHC 22C3 pharmDx the only companion diagnostic approved to detect tumors expressing PD-L1 in esophageal or GEJ carcinoma patients for KEYTRUDA treatmen
This approval represents the seventh FDA-approved companion diagnostic indication for PD-L1 IHC 22C3 pharmDx with KEYTRUDA
Subscribe To Our Newsletter & Stay Updated
